ABBOTINDIAHealthcare
Abbott India Limited
Pharmaceuticals · ISIN INE358A01014 · BSE 500488 · NSE EQ · FV ₹10
Last price
₹26,840
-1.05%today
What this company does
Abbott India Limited operates in Pharmaceuticals, part of the Healthcare sector.
Is this company doing well?
We don't have enough financial data on this company yet to summarise its health. Try one of the companies marked Full data in search.
Key ratios · latest quarter + price
₹26,840▼ -1.05%
latest close · 2026-10-01
1-year return
+29.6%
52-wk low ₹15,51452-wk high ₹28,940
More figures
Market cap
—
Book value
—
EPS
—
latest quarter
Net debt
—
Enterprise value
—
EBITDA
—
EBIT
—
Operating margin
—
Return on assets
—
Earnings yield
—
P/S
—
Sales / share
—
Tax rate
—
Face value
—
Working capital
—
Current assets
—
Current liabilities
—
P/E, ROE, ROCE and margins are annualised from the latest quarter; per-share and balance-sheet ratios use the most recent balance sheet on file · prices as of 2026-10-01.
Worth vs price · from the exchange filings
not investment adviceHard to value confidentlyLow confidence
We haven't parsed this company's annual profit history yet — common for banks and insurers, whose results file in a different format — so we can't value it off earnings.
An educational model from the company's own filings, every assumption shown — not investment advice or a price target. Prices can stay above or below any model for years.
Peer comparison
Pharmaceuticals · by market value
| Company | Price | Market cap | P/E | ROE | Net margin | 1-yr return |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹1,817 | ₹4.36 L cr | 37.5 | 13.9% | 18.9% | — |
| Divi's Laboratories Limited | ₹9,292 | ₹2.46 L cr | 68.4 | 21.5% | 29.3% | — |
| Torrent Pharmaceuticals Limited | ₹4,800 | ₹1.62 L cr | 80.7 | 27.0% | 11.5% | — |
| Zydus Lifesciences Limited | ₹1,162 | ₹1.16 L cr | 31.1 | 13.9% | 11.7% | — |
| Cipla Limited | ₹1,346 | ₹1.09 L cr | 34.4 | 9.2% | 11.1% | — |
| Laurus Labs Limited | ₹1,980 | ₹1.07 L cr | 72.7 | 27.7% | 18.1% | — |
| Mankind Pharma Limited | ₹2,504 | ₹1.03 L cr | 45.5 | 14.1% | 14.2% | — |
| Dr. Reddy's Laboratories Limited | ₹1,233 | ₹1.03 L cr | 57.8 | 4.7% | 5.5% | — |
| Aurobindo Pharma Limited | ₹1,672 | ₹96,207 cr | 23.4 | 10.9% | 11.3% | — |
Same industry · latest reported numbers · not a recommendation.
Corporate actions
Dividend yield
2.44%
trailing 12 months
Dividend / share (TTM)
₹656
Last dividend
₹525
ex 24 Jul 2026
| Action | Detail | Ex-date |
|---|---|---|
| Dividend | ₹525 / share | 24 Jul 2026 |
| Dividend | ₹131 / share | 24 Jul 2026 |
| Dividend | ₹475 / share | 25 Jul 2025 |
| Dividend | ₹410 / share | 19 Jul 2024 |
| Dividend | ₹180 / share | 21 Jul 2023 |
| Dividend | ₹145 / share | 21 Jul 2023 |
Smart-money activity
Bulk / block deals
short— · NSE7115 Sep 26
short— · NSE11 Jun 26
short— · NSE618 Mar 26
Stake changes
SoldReliance Capital Trustee Co Ltd A/c through various schemes of Reliance Mutual Fund→ 3.31% · 1.00 L1 Mar 17
How the stock has moved · adjusted for splits & bonuses
Data from primary exchange filings · analysis tool, not investment advice.